Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Inflammation‐mediated mechanisms for human neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) have evolved from being on the fringe of medical hypotheses to mainstream thinking. Pioneering immunopathology studies with human brain tissues identified microglia associated with neuropathologic hallmarks of these diseases. As activated macrophages were known to produce many potential toxic products, this gave rise to the hypothesis that activated microglia (brain resident macrophages) could be contributing to the degeneration of key target neurons in these diseases, as well as potential vascular dysfunction. Studies with microglia derived from different sources, including human brains, have confirmed that activated microglia can mediate neuronal cell death. Based on these theories, a number of human clinical trials with antiinflammatory agents have been carried out on AD patients. Results to date have indicated a lack of effectiveness at slowing disease progression and have begun to cast doubt on the significance of inflammation in AD. It has been shown recently that activating microglia through immunization of amyloid plaque‐developing mice with amyloid beta peptide (Aβ) has promise as a therapeutic strategy and despite some setbacks, has potential as a treatment for AD patients. This article will consider experimental data with microglia to determine whether the additional targets need to be investigated. The use of human microglia cultures, in particular those derived from elderly diseased human brains, offers an experimental system that can closely model the cell type activated in human neurodegenerative diseases. Experimental data produced by our laboratory and others is reviewed to determine the contribution of this unique experimental model to understanding disease mechanisms and possibly discovering new therapeutic targets. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · cited 1×
“Ab subfragment 10–20 activated the respiratory burst in human blood-derived macrophages (Van Muiswinkel et al., 1999), whereas region 25–35 resulted in increased oxygen free radical production by microglia, macrophages, and neutrophils (Yan et al., 1996; Della-Bianca et al., 1999).”
BackgroundAβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397 · cited 1×
“…of the brain of one immunized patient showed evidence that the development of specific antibodies to Ab led to the stimulation of microglia to remove Ab plaques (Nicoll et al., 2003); immunized patients also showed significant decreases in the rate of cognitive decline (Hock et al., 2003).”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Retrospective studies of patients with a long-term history of taking nonsteroidal antiinflammatory drugs (NSAIDs) showed a lower incidence of AD (Breitner et al., 1994, 1995; Andersen et al., 1995; McGeer et al., 1996; Stewart et al., 1997).”
BackgroundMCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · cited 1×
“…on transgenic mice as model systems for studying aspects of Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases (e.g., Campbell et al., 1993; Bornemann and Staufenbiel, 2000; Masliah et al., 2000; Matsuoka et al., 2001; DeMattos et al., 2002; Gong et al., 2003).”
BackgroundNeurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., & Mucke, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10061 · Cited by 1,006
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944 · cited 1×
“…of microglial nitric oxide production and its role in mediating neurotoxicity in rodent models of inflammation-associated neurodegeneration (e.g., Boje and Arora, 1992; Chao et al., 1992; Ishii et al., 2000; Combs et al., 2001; Xie et al., 2002; Melton et al., 2003; Chiarugi and Moskowitz, 2003;…”
BackgroundRelationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721 · cited 1×
“…oxide production and its role in mediating neurotoxicity in rodent models of inflammation-associated neurodegeneration (e.g., Boje and Arora, 1992; Chao et al., 1992; Ishii et al., 2000; Combs et al., 2001; Xie et al., 2002; Melton et al., 2003; Chiarugi and Moskowitz, 2003; Wang et al., 2004).”
BackgroundNSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo
Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S., Das, P., McLendon, D. C., Ozols, V. V., Jessing, K. W., Zavitz, K. H., Koo, E. H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18162 · Cited by 634 · cited 2×
“…it has now been suggested that NSAIDs may be effective in AD by a mechanism not associated with their antiinflammatory properties, but instead through decreasing the production of Ab (1–42), and thus preventing aggregation of Ab into plaques (Eriksen et al., 2003; Weggen et al., 2003a, 2003b).”
BackgroundMicroglia in degenerative neurological disease
McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 596
Self-citationQin, L., Liu, Y., Wang, T., Wei, S.-J., Block, M. L., Wilson, B., Liu, B., & Hong, J.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307657200 · Cited by 574 · cited 1×
“The involvement of NADPH oxidase activation by microglia has been implicated in neuronal cell death, particularly in association with loss of dopaminergic neurons (Gao et al., 2002, 2003; Qin et al., 2004).”
BackgroundDeMattos, R. B., Bales, K. R., Cummins, D. J., Paul, S. M., & Holtzman, D. M. (2002) · Science · doi:10.1126/science.1067568 · Cited by 563
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · cited 1×
“Studies have been carried out to demonstrate that activated microglia are a feature of PD (McGeer et al., 1988a; Knott et al., 2000; Le et al., 2001; Vila et al., 2001; Hirsch et al., 2003; Teismann et al., 2003).”
BackgroundLue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Self-citationActivation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383 · cited 1×
“Complement activation is a prominent feature of AD pathology, with Ab plaques and neurofibrillary tangles being immunoreactive for activation fragments of the classical complement pathway (McGeer et al., 1989; Neuroinflammation Working Group, 2000).”
BackgroundCytokines, chemokines, and cytokine receptors in human microglia
Lee, Y. B., Nagai, A., & Kim, S. U. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10253 · Cited by 363 · cited 3×
“Treatment of fetal microglia with Ab and LPS increased expression of IL-8, IL-10, IL-12, TNF-a, MIP-1a, MIP1b, and MCP-1 similar to what has been observed with adult microglia (Lee et al., 2002).”
BackgroundMethodResultMicroglia and Alzheimer's disease pathogenesis
Streit, W. J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20093 · Cited by 335 · cited 3×
“A novel ‘‘microglia dysfunction’’ theory for failure of microglia to clear AD-related cellular debris has been proposed recently (Streit, 2004).”
BackgroundResultInfluentialThe role of glial cells in Parkinsonʼs disease
Vila, M., Jackson-Lewis, V., Guégan, C., Chu Wu, D., Teismann, P., Choi, D.-K., Tieu, K., & Przedborski, S. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00009 · Cited by 326
β-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils
Della Bianca, V., Dusi, S., Bianchini, E., Dal Prà, I., & Rossi, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15493 · Cited by 324 · cited 2×
“Activation of the macrophage/microglia NADPH oxidase complex (respiratory burst) has been demonstrated to be a property of the Ab peptide (Klegeris et al., 1994; Giulian et al., 1995; McDonald et al., 1997; Della-Bianca et al., 1999; Van Muiswinkel et al., 1999; Lue and Walker, 2002).”
BackgroundControl of glial immune function by neurons
Neumann, H. (2001) · Glia · doi:10.1002/glia.1108 · Cited by 319
Matsuoka, Y., Vila, M., Lincoln, S., McCormack, A., Picciano, M., LaFrancois, J., Yu, X., Dickson, D., Langston, W. J., McGowan, E., et al. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0392 · Cited by 281 · cited 1×
“…on transgenic mice as model systems for studying aspects of Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases (e.g., Campbell et al., 1993; Bornemann and Staufenbiel, 2000; Masliah et al., 2000; Matsuoka et al., 2001; DeMattos et al., 2002; Gong et al., 2003).”
Xie, Z., Wei, M., Morgan, T. E., Fabrizio, P., Han, D., Finch, C. E., & Longo, V. D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03484.2002 · Cited by 272
Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain
Giulian, D., Haverkamp, L. J., Li, J., Karshin, W. L., Yu, J., Tom, D., Li, X., & Kirkpatrick, J. B. (1995) · Neurochemistry International · doi:10.1016/0197-0186(95)00067-i · Cited by 242 · cited 5×
“It has been demonstrated that microglia (both human and rodent) stimulated with AD brain-derived amyloid or synthetic Ab peptide produced a factor that was directly neurotoxic to primary hippocampal neurons (Giulian et al., 1995, 1996, 1998).”
BackgroundInfluentialKuo, Y.-M., Beach, T. G., Sue, L. I., Scott, S., Layne, K. J., Kokjohn, T. A., Kalback, W. M., Luehrs, D. C., Vishnivetskaya, T. A., Abramowski, D., et al. (2001) · Molecular Medicine · doi:10.1007/bf03401867 · Cited by 90
Occurrence of HLA‐DR Reactive Microglia in Alzheimer's Disease
McGEER, P. L., ITAGAKI, S., TAGO, H., & McGEER, E. G. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb27086.x · Cited by 57
Differential effects of Th1 and Th2 lymphocyte supernatants on human microglia
Séguin, R., Biernacki, K., Prat, A., Wosik, K., Kim, H., Blain, M., Mccrea, E., Bar‐Or, A., & Antel, J. P. (2003) · Glia · doi:10.1002/glia.10201 · Cited by 40 · cited 1×
“…has been principally on investigation into role of microglia as antigen-presenting cells, their interaction with peripheral lymphocytes, and mechanisms related to the cause of multiple sclerosis (Williams et al., 1994b; Becher et al., 2000; Chan et al., 2003; Seguin et al., 2003; Kim et al., 2004).”
BackgroundAisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Cited by
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Review: Activation patterns of microglia and their identification in the human brain
Boche, D., Perry, V. H., & Nicoll, J. A. R. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12011 · Cited by 912
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
Role of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493
“Consequently, some investigators have proposed that microglia could play a neuroprotective role as well as pathogenetic role in the aetiology of the disease (Town et al., 2001; Schenk and Yednock, 2002; Morgan et al., 2005; Walker and Lue, 2005).”
Background
Metadata
- Authors
- Walker, D. G., & Lue, L.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2005-06-14
- Volume
- 81
- Issue
- 3
- Pages
- 412-425
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2102553417
- Cited by
- 89
- References
- 33
- FWCI
- 4.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.